Pharmaceutical

Novartis is tapping into Argo Biopharmaceutical's siRNA capabilities again in a deal worth up to $5.2 billion. The FDA approved a subcutaneous version...

A little less than a year after targeting Moderna in an mRNA vaccine patent lawsuit, GSK is widening the scope of its litigation by throwing its rival...

As the maker of Veozah, which treats menopause-related vasomotor symptoms, Astellas Pharma has a vested interest in breaking down the societal stigma...

In April, the FDA sounded a familiar warning to consumers of an ongoing problem in the United States—the sale of unauthorized compounded and counterfe...

With hundreds of workers on strike at Perrigo’s plant in the Bronx, it appears some employees have tacked on a fourth “S” to the company’s “Three S” r...

Spending on point-of-care drug marketing is on the rise. The Point of Care Marketing Association (POCMA) reports that total annual revenues of its mem...

Five months after embarking on a “massive testing and research effort” to root out the cause of the nation's "autism epidemic," Robert F. Kennedy Jr....

A newly launched startup is the latest young company to build itself around a drug discovered in Chinese laboratories. Hengrui Pharma on Friday said i...

Today, a brief rundown of news involving the Food and Drug Administration and Gilead Sciences, as well as updates from AC Immune, Agios Pharmaceutical...

It was déjà vu all over again for TV drug ad spending in August, as the top 10 spenders barely deviated from July’s list and turned in a combined tota...